Active — Not RecruitingNot Applicable

Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions

United States266 participantsStarted 2023-11-24

Plain-language summary

The study will evaluate the effectiveness of the Just Care for Families program in preventing Oregon Department of Human Services (ODHS)-involved parents in rural communities from escalating opioid and/or methamphetamine use and mental health disorders by disrupting the associated social risk factors of health (SRFOH). In addition, investigators will examine the impacts of SRFOH on Just Care treatment and the associated costs from the perspective of provider clinics delivering Just Care. Just Care is a behavioral intervention for the treatment of parental substance abuse and child neglect for families involved in the child welfare system. Just Care involves treatment components, supported by ongoing purposeful engagement: (1) Substance use treatment; (2) Mental health treatment; (3) Parent management training; (4) Community building; (5) Systems Navigation; and (6) Addressing basic needs. This study is supported by and included in the Helping to End Addiction Long-term Initiative (https://heal.nih.gov/).

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Parents: * Any substance misuse in the last year * Parent of a child, age 0-18 * Resident of participating county (Lane, Linn, Benton, Douglas, Lincoln) * Insured by Oregon Health Plan (Medicaid) * Access to a computer or smartphone; or wireless/cellular connection if a device were to be provided; or reliable access to a landline to receive a brief weekly phone assessment in place of the digital assessment Clinical Staff: * clinician at a participating clinic * Providing Just Care for Families services to parents in the study at any point during study Exclusion Criteria: * Alcohol use disorder

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in opioid use

Timeframe: baseline, 9 months, and 18 months

Change in methamphetamine use

Timeframe: baseline, 9 months, 18 months

Change in depression severity

Timeframe: Baseline, 9 months and 18 months

Change in anxiety

Timeframe: baseline, 9 months, 18 months

Change in Social Risk Factors Needs

Timeframe: Baseline through 18 months (weekly)

Trial details

NCT IDNCT06560866

SponsorChestnut Health Systems

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-30

View on ClinicalTrials.gov More Substance-Related Disorders trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in opioid use

Timeframe: baseline, 9 months, and 18 months

Change in methamphetamine use

Timeframe: baseline, 9 months, 18 months

Change in depression severity

Timeframe: Baseline, 9 months and 18 months

Change in anxiety

Timeframe: baseline, 9 months, 18 months

Change in Social Risk Factors Needs

Timeframe: Baseline through 18 months (weekly)